Miltenyi Biotec’s mission is to improve scientific understanding and medical progress. By developing innovative products that address the processes that are necessary for the study of immuno-oncology we help researchers advance science in these key areas as well as help clinicians to make the concept of cellular therapy a reality.
Data-driven and highly-targeted immunotherapies are the future of the fight against cancer. IsoPlexis, develops novel solutions that are accelerating the revolution in immune and cell-based treatments of cancer. The Isolight, a next-generation analytics platform, profiles responses at the single-cell level enabling researchers to generate a precise functional patient signature to help predict and understand complex response to cancer immunotherapies. Isoplexis has partnered with leading biopharmaceutical companies and trial centers to generate real-world data to advance high-need areas of cell product characterization, immune biomarker discovery, and patient monitoring.
HebeCell’s first-in-class proprietary 3D manufacture platform for human iPS-NK cells is feeder-free, designed for single-use-bioreactor at industrial scale. By eliminating exhaustive feeder-dependent expansion, our platform offers a truly viable unlimited source of immune cells with improved potency and simplified manufacture process. Our goal is to unlock the true power of NK cells in fighting cancer, autoimmune and infectious diseases.
The Jackson Laboratory
The Jackson Laboratory is a leading provider of cancer mouse models and in vivo oncology services and a National Cancer Institute designated Cancer Center. Drawing on decades of research experience we provide capabilities around model selection, husbandry and customizable oncology studies to help clients and researchers evaluate novel anti-cancer therapies. Our diverse oncology study protocols range from traditional xenograft services to PDX cancer models and advanced humanized mouse models for immuno-oncology drug development.
Bio-Techne is a global life science company providing innovative products and resources for the research and clinical diagnostic communities. Our expertise across three operating divisions spans laboratory research, preclinical and clinical studies, and reagents for manufacturing therapeutic and diagnostic tests, making us uniquely suited to serve the immune cell therapy research community. We develop and manufacture NK cell isolation and expansion kits, specialized NK cell culture media, and high-quality proteins, and we have established ourselves as the world leader in immunoassays.
Since our start in 2006, research and development efforts at Akron Biotech have led to discoveries that have fuelled the development of some of the most innovative products to support cell and gene therapy research, clinical development and commercialization. Now, Akron operates from a 14,000 sf facility in Boca Raton as a leader in innovation and cGMP manufacturing.
Fresenius Kabi is a leading global health company that focuses on pharmaceuticals and medical devices used to care for critically and chronically ill patients. We bring over 60 years of experience advancing the fields of cell collection and separation with expertise in closed-system processing. Our Lovo Cell Processing System is the only cell processing system that washes and concentrates white blood cells using filtration technology, specifically to serve the needs of the cellular therapies community.
Beacon Targeted Therapies
Beacon Targeted Therapies, a competitive and research intelligence database solution designed in partnership with pharmaceutical professionals across the world working in targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.
Find out more on how we can help you by visiting